484 related articles for article (PubMed ID: 33341233)
1. The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
Jans DA; Wagstaff KM
Biochem Biophys Res Commun; 2021 Jan; 538():163-172. PubMed ID: 33341233
[TBL] [Abstract][Full Text] [Related]
2. Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
Jans DA; Wagstaff KM
Cells; 2020 Sep; 9(9):. PubMed ID: 32942671
[TBL] [Abstract][Full Text] [Related]
3. Antivirals that target the host IMPα/β1-virus interface.
Martin AJ; Jans DA
Biochem Soc Trans; 2021 Feb; 49(1):281-295. PubMed ID: 33439253
[TBL] [Abstract][Full Text] [Related]
4. The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer.
Yang SNY; Atkinson SC; Wang C; Lee A; Bogoyevitch MA; Borg NA; Jans DA
Antiviral Res; 2020 May; 177():104760. PubMed ID: 32135219
[TBL] [Abstract][Full Text] [Related]
5. Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication.
Low ZY; Yip AJW; Lal SK
Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166294. PubMed ID: 34687900
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin.
King CR; Tessier TM; Dodge MJ; Weinberg JB; Mymryk JS
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641484
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2.
Kinobe RT; Owens L
Fundam Clin Pharmacol; 2021 Apr; 35(2):260-276. PubMed ID: 33427370
[TBL] [Abstract][Full Text] [Related]
8. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
9. An
Azam F; Taban IM; Eid EEM; Iqbal M; Alam O; Khan S; Mahmood D; Anwar MJ; Khalilullah H; Khan MU
J Biomol Struct Dyn; 2022 Apr; 40(6):2851-2864. PubMed ID: 33131430
[TBL] [Abstract][Full Text] [Related]
10. From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
Rakedzon S; Neuberger A; Domb AJ; Petersiel N; Schwartz E
J Travel Med; 2021 Feb; 28(2):. PubMed ID: 33480414
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.
Li N; Zhao L; Zhan X
J Cell Physiol; 2021 Apr; 236(4):2959-2975. PubMed ID: 32959892
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.
Heidary F; Gharebaghi R
J Antibiot (Tokyo); 2020 Sep; 73(9):593-602. PubMed ID: 32533071
[TBL] [Abstract][Full Text] [Related]
13. Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients.
Segatori VI; Garona J; Caligiuri LG; Bizzotto J; Lavignolle R; Toro A; Sanchis P; Spitzer E; Krolewiecki A; Gueron G; Alonso DF
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696514
[TBL] [Abstract][Full Text] [Related]
14. Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities.
Wehbe Z; Wehbe M; Iratni R; Pintus G; Zaraket H; Yassine HM; Eid AH
Front Immunol; 2021; 12():663586. PubMed ID: 33859652
[TBL] [Abstract][Full Text] [Related]
15. Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols.
Marques LLM; Beneti SC; Pinzon C; Cardoso FAR
Braz J Biol; 2022; 84():e258325. PubMed ID: 35584459
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin: an award-winning drug with expected antiviral activity against COVID-19.
Formiga FR; Leblanc R; de Souza Rebouças J; Farias LP; de Oliveira RN; Pena L
J Control Release; 2021 Jan; 329():758-761. PubMed ID: 33038449
[TBL] [Abstract][Full Text] [Related]
17. Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication.
Lundberg L; Pinkham C; Baer A; Amaya M; Narayanan A; Wagstaff KM; Jans DA; Kehn-Hall K
Antiviral Res; 2013 Dec; 100(3):662-72. PubMed ID: 24161512
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach.
González-Paz L; Hurtado-León ML; Lossada C; Fernández-Materán FV; Vera-Villalobos J; Loroño M; Paz JL; Jeffreys L; Alvarado YJ
Biophys Chem; 2021 Nov; 278():106677. PubMed ID: 34428682
[TBL] [Abstract][Full Text] [Related]
19. Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus.
Wagstaff KM; Sivakumaran H; Heaton SM; Harrich D; Jans DA
Biochem J; 2012 May; 443(3):851-6. PubMed ID: 22417684
[TBL] [Abstract][Full Text] [Related]
20. Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?
Dicks LMT; Deane SM; Grobbelaar MJ
Probiotics Antimicrob Proteins; 2022 Apr; 14(2):217-223. PubMed ID: 35218001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
